FOLH1 and cancer: Bagalkot and colleagues showed that QDs can be used for both imaging and therapy; QD-apatamer (Apt)-doxorubicin (Dox) conjugate was used for targeted cancer therapy and imaging of prostate cancer cells that express prostate-specific membrane antigen (PSMA) protein [14].